Erste Asset Management Gmb H Janux Therapeutics, Inc. Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 27,000 shares of JANX stock, worth $715,770. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,000
Previous 27,000
-0.0%
Holding current value
$715,770
Previous $786 Million
20.45%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding JANX
# of Institutions
186Shares Held
56MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$297 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$118 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$77.4 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$66.9 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$62.1 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.1B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...